Low‐dose oral minoxidil increases hair density and thickness in androgenetic alopecia: A retrospective analysis of 60 patients

Author(s):  
L Yin ◽  
K Svigos ◽  
D Gutierrez ◽  
E Peterson ◽  
K Lo Sicco ◽  
...  
Author(s):  
Baltazar Sanabria ◽  
Tamara de Nardo Vanzela ◽  
Hélio Amante Miot ◽  
Paulo Müller Ramos

2019 ◽  
Vol 81 (2) ◽  
pp. 648-649 ◽  
Author(s):  
Juan Jimenez-Cauhe ◽  
David Saceda-Corralo ◽  
Rita Rodrigues-Barata ◽  
Angela Hermosa-Gelbard ◽  
Oscar M. Moreno-Arrones ◽  
...  

2020 ◽  
Vol 82 (1) ◽  
pp. e23-e24 ◽  
Author(s):  
Juan Jimenez-Cauhe ◽  
David Saceda-Corralo ◽  
Oscar M. Moreno-Arrones ◽  
Daniel Ortega-Quijano ◽  
Diego Fernandez-Nieto ◽  
...  

2020 ◽  
Vol 83 (5) ◽  
pp. 1491-1493 ◽  
Author(s):  
Abhijeet Kumar Jha ◽  
Sidharth Sonthalia ◽  
MD Zeeshan ◽  
Keshavamurthy Vinay

2001 ◽  
Vol 1 (3) ◽  
pp. 123-131 ◽  
Author(s):  
J. Michael Maloney ◽  
Deborah I. Arbit ◽  
Mary Flack ◽  
Constance McLaughlin-Miley ◽  
Cynthia Sevilla ◽  
...  

2001 ◽  
Vol 21 (02) ◽  
pp. 77-81 ◽  
Author(s):  
G. Finazzi

SummaryThrombotic events are a major clinical problem for patients with antiphospholipid antibodies (APA). However, current recommendations for their prevention and treatment are still based on retrospective studies. Data from large scale, prospective clinical trials are required to ultimately identify the optimal management of these patients. To date, at least four randomized studies are underway. The WAPS and PAPRE clinical trials are aimed to establish the correct duration and intensity of oral anticoagulation in APA patients with major arterial or venous thrombosis. The WARSS-APASS is a collaborative study to evaluate the efficacy and safety of aspirin or low-dose oral anticoagulants in preventing the recurrence of ischemic stroke. The recently announced UK Trial compares low-dose aspirin with or without low-intensity anticoagulation for the primary prevention of vascular events in APA-positive patients with SLE or adverse pregnancy history, but still thrombosis-free. It is hoped that the results of these trials will be available soon since clinicians urgently need more powerful data to treat their patients with the APA syndrome.


1992 ◽  
Vol 68 (02) ◽  
pp. 160-164 ◽  
Author(s):  
P J Braun ◽  
K M Szewczyk

SummaryPlasma levels of total prothrombin and fully-carboxylated (native) prothrombin were compared with results of prothrombin time (PT) assays for patients undergoing oral anticoagulant therapy. Mean concentrations of total and native prothrombin in non-anticoagulated patients were 119 ± 13 µg/ml and 118 ± 22 µg/ml, respectively. In anticoagulated patients, INR values ranged as high as 9, and levels of total prothrombin and native prothrombin decreased with increasing INR to minimum values of 40 µg/ml and 5 µg/ml, respectively. Des-carboxy-prothrombin increased with INR, to a maximum of 60 µg/ml. The strongest correlation was observed between native prothrombin and the reciprocal of the INR (1/INR) (r = 0.89, slope = 122 µg/ml, n = 200). These results indicated that native prothrombin varied over a wider range and was more closely related to INR values than either total or des-carboxy-prothrombin. Levels of native prothrombin were decreased 2-fold from normal levels at INR = 2, indicating that the native prothrombin antigen assay may be a sensitive method for monitoring low-dose oral anticoagulant therapy. The inverse relationship between concentration of native prothrombin and INR may help in identification of appropriate therapeutic ranges for oral anticoagulant therapy.


Sign in / Sign up

Export Citation Format

Share Document